General Anxiety Disorder Pipeline Assessment Overview H1 2015 Research Report
The report "General Anxiety Disorder – Pipeline Review, H1 2015 " provides comprehensive information on the therapeutic development for General Anxiety Disorder, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for General Anxiety Disorder and special features on late-stage and discontinued projects.
View full press release